Skip navigation
Please use this identifier to cite or link to this item: http://repository.iitr.ac.in/handle/123456789/1259
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMalik A.-
dc.contributor.authorDalal V.-
dc.contributor.authorAnkri S.-
dc.contributor.authorTomar, Shailly-
dc.date.accessioned2020-09-30T11:33:42Z-
dc.date.available2020-09-30T11:33:42Z-
dc.date.issued2019-
dc.identifier.citationFEBS Journal(2019), 286(20): 4135-4155-
dc.identifier.issn1742464X-
dc.identifier.other31199070-
dc.identifier.urihttps://doi.org/10.1111/febs.14960-
dc.identifier.urihttp://repository.iitr.ac.in/handle/123456789/1259-
dc.description.abstractArginase, the binuclear metalloenzyme, is a potential target for therapeutic intervention in protozoan infections. Entamoeba histolytica infection causes amebiasis which is the second most common cause of protozoan-related human deaths after malaria. Here, we report the crystal structure of E. histolytica arginase (EhArg) in complex with two known inhibitors N?-hydroxy-l-arginine (l-NOHA) and l-norvaline, and its product l-ornithine at 1.7, 2.0, and 2.4 Å, respectively. Structural and comparative analysis of EhArg–inhibitor complexes with human arginase revealed that despite only 33% sequence identity, the structural determinants of inhibitor recognition and binding are highly conserved in arginases with variation in oligomerization motifs. Knowledge regarding the spatial organization of residues making molecular contacts with inhibitory compounds enabled in the identification of four novel non-amino acid inhibitors, namely irinotecan, argatroban, cortisone acetate, and sorafenib. In vitro testing of the in silico-identified inhibitors using purified enzyme proved that irinotecan, argatroban, cortisone acetate, and sorafenib inhibit EhArg with IC50 value (mm) of 1.99, 2.40, 0.91, and 2.75, respectively, as compared to the known inhibitors l-NOHA and l-norvaline with IC50 value (mm) of 1.57 and 17.9, respectively. The identification of structure-based non-amino acid inhibitory molecules against arginase will be constructive in design and discovery of novel chemical modulators for treating amebiasis by directed therapeutics. © 2019 Federation of European Biochemical Societies-
dc.language.isoen_US-
dc.publisherBlackwell Publishing Ltd-
dc.relation.ispartofFEBS Journal-
dc.subjectarginase-
dc.subjectcrystal structure-
dc.subjectEntamoeba histolytica-
dc.subjectl-norvaline-
dc.subjectstructure-based drug designing-
dc.titleStructural insights into Entamoeba histolytica arginase and structure-based identification of novel non-amino acid based inhibitors as potential antiamoebic molecules-
dc.typeArticle-
dc.scopusid57191902133-
dc.scopusid57194227044-
dc.scopusid6701672273-
dc.scopusid57203506001-
dc.affiliationMalik, A., Department of Biotechnology, Indian Institute of Technology Roorkee, India-
dc.affiliationDalal, V., Department of Biotechnology, Indian Institute of Technology Roorkee, India-
dc.affiliationAnkri, S., Department of Molecular Microbiology, Bruce Rappaport Faculty of Med-
dc.description.fundingAM thanks University Grant Commission (UGC) and VD thanks the Department of Biotechnology (DBT/2015/IIT-R/349) for financial support. AM and VD thank Macromolecular Crystallographic Unit (MCU), a Central Facility at Institute Instrumentation Centre (IIC),-
dc.description.correspondingauthorTomar, S.; Department of Biotechnology, Indian Institute of Technology RoorkeeIndia; email: shailfbt@iitr.ac.in-
Appears in Collections:Journal Publications [BT]

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.